Cargando…

LPA(1) antagonist BMS-986020 changes collagen dynamics and exerts antifibrotic effects in vitro and in patients with idiopathic pulmonary fibrosis

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a debilitating lung disease with limited treatment options. A phase 2 trial (NCT01766817) showed that twice-daily treatment with BMS-986020, a lysophosphatidic acid receptor 1 (LPA(1)) antagonist, significantly decreased the slope of forced vital ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Decato, Benjamin E., Leeming, Diana Julie, Sand, Jannie Marie Bülow, Fischer, Aryeh, Du, Shuyan, Palmer, Scott M., Karsdal, Morten, Luo, Yi, Minnich, Anne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933988/ https://www.ncbi.nlm.nih.gov/pubmed/35303880 http://dx.doi.org/10.1186/s12931-022-01980-4

Ejemplares similares

BMS-986020, a Specific LPA(1) Antagonist, Provides Neuroprotection against Ischemic Stroke in Mice
por: Gaire, Bhakta Prasad, et al.
Publicado: (2020)

Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA(1)) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic interstitial lung disease (PF-ILD)
por: Corte, Tamera J, et al.
Publicado: (2021)

Development of a Novel Enzyme-Linked Immunosorbent Assay Targeting a Neo-Epitope Generated by Cathepsin-Mediated Turnover of Type III Collagen and Its Application in Chronic Obstructive Pulmonary Disease
por: Rasmussen, Daniel Guldager Kring, et al.
Publicado: (2017)

Type IV collagen turnover is predictive of mortality in COPD: a comparison to fibrinogen in a prospective analysis of the ECLIPSE cohort
por: Rønnow, Sarah Rank, et al.
Publicado: (2019)

Serum Type XIX Collagen is Significantly Elevated in Non-Small Cell Lung Cancer: A Preliminary Study on Biomarker Potential
por: Thorlacius-Ussing, Jeppe, et al.
Publicado: (2020)

Biomarkers of extracellular matrix turnover are associated with emphysema and eosinophilic-bronchitis in COPD
por: Bihlet, Asger Reinstrup, et al.
Publicado: (2017)

Nintedanib modulates type III collagen turnover in viable precision-cut lung slices from bleomycin-treated rats and patients with pulmonary fibrosis
por: Hesse, Christina, et al.
Publicado: (2022)

High levels of biomarkers of collagen remodeling are associated with increased mortality in COPD – results from the ECLIPSE study
por: Sand, Jannie M. B., et al.
Publicado: (2016)

Biomarkers of collagen turnover are related to annual change in FEV(1) in patients with chronic obstructive pulmonary disease within the ECLIPSE study
por: Leeming, Diana J., et al.
Publicado: (2017)

Serological Investigation of the Collagen Degradation Profile of Patients with Chronic Obstructive Pulmonary Disease or Idiopathic Pulmonary Fibrosis
por: Leeming, Diana J., et al.
Publicado: (2012)

Longitudinal serological assessment of type VI collagen turnover is related to progression in a real-world cohort of idiopathic pulmonary fibrosis
por: Jessen, Henrik, et al.
Publicado: (2021)

Serum markers of the extracellular matrix remodeling reflect antifibrotic therapy in bile-duct ligated rats
por: Schierwagen, Robert, et al.
Publicado: (2013)

MMP Mediated Degradation of Type IV Collagen Alpha 1 and Alpha 3 Chains Reflects Basement Membrane Remodeling in Experimental and Clinical Fibrosis – Validation of Two Novel Biomarker Assays
por: Sand, Jannie Marie, et al.
Publicado: (2013)

A serological biomarker of type I collagen degradation is related to a more severe, high neutrophilic, obese asthma subtype
por: Rønnow, Sarah Rank, et al.
Publicado: (2022)

Dapagliflozin: BMS 512148; BMS-512148
Publicado: (2012)

Specific elastin degradation products are associated with poor outcome in the ECLIPSE COPD cohort
por: Rønnow, Sarah Rank, et al.
Publicado: (2019)

Serological assessment of neutrophil elastase activity on elastin during lung ECM remodeling
por: Kristensen, Jacob H, et al.
Publicado: (2015)

Fibroblasts are not just fibroblasts: clear differences between dermal and pulmonary fibroblasts’ response to fibrotic growth factors
por: Madsen, Sofie Falkenløve, et al.
Publicado: (2023)

BMS‐986263 in patients with advanced hepatic fibrosis: 36‐week results from a randomized, placebo‐controlled phase 2 trial
por: Lawitz, Eric J., et al.
Publicado: (2021)

Association of Systemic Collagen Type IV Formation with Survival among Patients Undergoing Hemodialysis
por: Leeming, Diana J., et al.
Publicado: (2013)

LPA(1), LPA(2), LPA(4), and LPA(6) receptor expression during mouse brain development
por: Suckau, Olga, et al.
Publicado: (2019)

Phosphodiesterase inhibition mediates matrix metalloproteinase activity and the level of collagen degradation fragments in a liver fibrosis ex vivo rat model
por: Veidal, Sanne Skovgård, et al.
Publicado: (2012)

Turnover of type I and III collagen predicts progression of idiopathic pulmonary fibrosis
por: Jessen, H., et al.
Publicado: (2021)

A Serological Biomarker of Versican Degradation is Associated with Mortality Following Acute Exacerbations of Idiopathic Interstitial Pneumonia
por: Sand, Jannie M. B., et al.
Publicado: (2018)

Collagen triple helix repeat containing-1 exerts antifibrotic effects on human skin fibroblast and bleomycin-induced dermal fibrosis models
por: Shen, Zhu, et al.
Publicado: (2021)

Phosphorylation and Internalization of Lysophosphatidic Acid Receptors LPA(1), LPA(2), and LPA(3)
por: Alcántara-Hernández, Rocío, et al.
Publicado: (2015)

Effect of pegbelfermin on NASH and fibrosis-related biomarkers and correlation with histological response in the FALCON 1 trial
por: Brown, Elizabeth A., et al.
Publicado: (2023)

Prolonged Scar-in-a-Jar: an in vitro screening tool for anti-fibrotic therapies using biomarkers of extracellular matrix synthesis
por: Rønnow, Sarah Rank, et al.
Publicado: (2020)

Erratum to collagen triple helix repeat containing-1 exerts antifibrotic effects on human skin fibroblast and bleomycin-induced dermal fibrosis models
Publicado: (2022)

The Extra Virgin Olive Oil Polyphenol Oleocanthal Exerts Antifibrotic Effects in the Liver
por: Gabbia, Daniela, et al.
Publicado: (2021)

Galunisertib Exerts Antifibrotic Effects on TGF-β-Induced Fibroproliferative Dermal Fibroblasts
por: Peterson, Joshua M., et al.
Publicado: (2022)

Accelerated extracellular matrix turnover during exacerbations of COPD
por: Sand, Jannie M. B., et al.
Publicado: (2015)

Crystal structures of trimeric HIV Env with entry inhibitors BMS-378806 and BMS-626529
por: Pancera, Marie, et al.
Publicado: (2017)

Combining biomarkers of clot resolution and alveolar basement membrane destruction predicts mortality in the ECLIPSE COPD cohort
por: Sand, Jannie M.B., et al.
Publicado: (2020)

Endotrophin, an extracellular hormone, in combination with neoepitope markers of von Willebrand factor improves prediction of mortality in the ECLIPSE COPD cohort
por: Rønnow, Sarah R., et al.
Publicado: (2020)

Increased von Willebrand Factor Processing in COPD, Reflecting Lung Epithelium Damage, Is Associated with Emphysema, Exacerbations and Elevated Mortality Risk
por: Langholm, Lasse L, et al.
Publicado: (2020)

Regulation of T Cell Motility In Vitro and In Vivo by LPA and LPA2
por: Knowlden, Sara A., et al.
Publicado: (2014)

Barrel-muon-spectrometer: BMS
Publicado: (2005)

Barrel-muon-spectrometer: BMS
Publicado: (2005)

Barrel-muon-spectrometer: BMS
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_709qjcqjuru4cl12phpae7sba9